Sunrise Medical, Inc.
Sunrise Medical, Inc., a leading name in the mobility and rehabilitation industry, is headquartered in the United States. Founded in 1983, the company has established itself as a pioneer in designing and manufacturing high-quality mobility solutions, including wheelchairs, power chairs, and seating systems. With a strong presence in North America, Europe, and Asia, Sunrise Medical is committed to enhancing the quality of life for individuals with mobility challenges. The company’s core products, such as the Quickie and Jazzy brands, are renowned for their innovative designs and advanced technology, setting them apart in the competitive market. Sunrise Medical has achieved significant milestones, including numerous industry awards for product excellence and customer satisfaction. As a trusted partner in the healthcare sector, Sunrise Medical continues to lead the way in providing exceptional mobility solutions tailored to individual needs.
DitchCarbon Score
How does Sunrise Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sunrise Medical, Inc.'s score of 27 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sunrise Medical, Inc.'s reported carbon emissions
Sunrise Medical, Inc., headquartered in the US, has set ambitious climate commitments aimed at significantly reducing its carbon emissions. Although specific emissions data for the most recent year is not available, the company has established clear reduction targets for its greenhouse gas emissions. Sunrise Medical is committed to reducing its absolute Scope 1 and Scope 2 greenhouse gas emissions by 43% by 30 June 2030, based on a 2021 baseline. This commitment reflects a proactive approach to mitigating climate impact and aligns with industry standards for sustainability. In addition to its near-term goals, Sunrise Medical has also set long-term targets through its subsidiary, Sunrise GmbH. The company aims to achieve a 51% reduction in absolute Scope 1 and Scope 2 emissions by 2032, using 2022 as the base year. Furthermore, it has committed to a 30% reduction in absolute Scope 3 emissions within the same timeframe. These targets are consistent with the Science Based Targets initiative (SBTi) and are designed to support global efforts to limit temperature rise to 1.5°C. Overall, Sunrise Medical, Inc. demonstrates a strong commitment to sustainability and climate action, with a focus on substantial emissions reductions across its operations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sunrise Medical, Inc. is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
